HS-10374 tablets

DRUG2 trials

Sponsors

Jiangsu Hansoh Pharmaceutical Co., Ltd., Hansoh BioMedical R&D Company

Conditions

PsoriasisPsoriasis (PsO)

Phase 1

A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10374 in Healthy Subjects

CompletedNCT06033742

Jiangsu Hansoh Pharmaceutical Co., Ltd.Psoriasis

Start: 2021-11-13End: 2023-03-24Updated: 2023-09-13

A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin®)

CompletedNCT07181343

Hansoh BioMedical R&D CompanyPsoriasis (PsO)

Start: 2025-05-28End: 2025-08-19Updated: 2025-09-18